Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PARC (Palo Alto Research Center), an SRI International company, is a world-renowned research and development organization that translates breakthrough science into commercial technology. While historically famous for computing innovations, PARC maintains a robust Health & Wellness division focused on medical devices, point-of-care diagnostics, and digital health. Their expertise includes microfluidics for liquid biopsies, advanced sensors for monitoring chronic conditions, and AI-driven platforms for behavioral health intervention. PARC utilizes a unique 'Open Innovation' model, partnering with global corporations and government agencies like DARPA and NIH to develop and license new technologies. The center's work in life sciences often bridges the gap between physical sciences and biology, resulting in high-throughput screening and novel drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palo Alto Research Center.